Tus kws kho mob
P57-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 03, 2024
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1181 - 1190 ntawm 4139
Tus kws kho mob
QP68-24 MHCP Pharmacy Benefit Exclusion for Kisunla™, PiaSky®, and Tecelra®
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 28, 2024
Tus kws kho mob
QP67-24 Commercial Pharmacy Benefit Exclusion for edaravone, Kisunla™, PiaSky®, and Tecelra®
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 28, 2024
Tus kws kho mob
QP65-24 PCA Agency Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 28, 2024
Tus kws kho mob
QP66-24 Reminder: Patient Complaint Policy and Process Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 28, 2024
Tus kws kho mob
QP62-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 14, 2024
Ntawv Thov Nyiaj Rov Qab thiab Kev Thov Kom Rov Txiav Txim Dua
Cov Txiaj Ntsig thiab Kev Duav Roos
Blue Plus Member Authorization form
Tus kws kho mob
QP64-24 MHCP Pharmacy Benefit Exclusion for Rytelo™
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 14, 2024
Tus kws kho mob
QP63-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 14, 2024
Cov Ntaub Ntawv Qhia Paub Fab Nyiaj Txiag
Tus kws kho mob
medicaid-anesthesia-001.pdf